Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

  • Hironori Ninomiya1,
  • Motohiro Kato4, 5,
  • Masashi Sanada4,
  • Kengo Takeuchi1, 2,
  • Kentaro Inamura1,
  • Noriko Motoi1,
  • Hiroko Nagano1,
  • Kimie Nomura1,
  • Yukinori Sakao3,
  • Sakae Okumura3,
  • Hiroyuki Mano6, 7,
  • Seishi Ogawa4 and
  • Yuichi Ishikawa1Email author
BMC Cancer201313:8

DOI: 10.1186/1471-2407-13-8

Received: 6 April 2012

Accepted: 18 December 2012

Published: 5 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Jun 2012 Reviewed Reviewer Report - Marileila Varella-Garcia
19 Jun 2012 Reviewed Reviewer Report - Keith Kerr
22 Jun 2012 Reviewed Reviewer Report - Elisabeth BRAMBILLA
22 Sep 2012 Author responded Author comments - Yuichi Ishikawa
Resubmission - Version 3
22 Sep 2012 Submitted Manuscript version 3
5 Oct 2012 Reviewed Reviewer Report - Marileila Varella-Garcia
Resubmission - Version 4
Submitted Manuscript version 4
17 Oct 2012 Reviewed Reviewer Report - Elisabeth BRAMBILLA
18 Oct 2012 Author responded Author comments - Yuichi Ishikawa
Resubmission - Version 5
18 Oct 2012 Submitted Manuscript version 5
5 Dec 2012 Author responded Author comments - Yuichi Ishikawa
Resubmission - Version 6
5 Dec 2012 Submitted Manuscript version 6
Publishing
18 Dec 2012 Editorially accepted
5 Jan 2013 Article published 10.1186/1471-2407-13-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Pathology, The Cancer Institute
(2)
Pathology Project for Molecular Targets, The Cancer Institute
(3)
Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research
(4)
Cancer Genomics Project, The University of Tokyo
(5)
Department of Pediatrics, The University of Tokyo
(6)
Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo
(7)
Division of Functional Genomics, Jichi Medical University

Advertisement